Nolan, Brendan J. http://orcid.org/0000-0001-8836-165X
Proietto, Joseph http://orcid.org/0000-0002-8517-2076
Sumithran, Priya http://orcid.org/0000-0002-9576-1050
Funding for this research was provided by:
National Health and Medical Research Council (1178482)
Article History
Received: 11 January 2022
Accepted: 21 April 2022
First Online: 7 May 2022
Compliance with ethical standards
:
: B.J.N. reports fees from iNova pharmaceuticals for lectures unrelated to the submitted work. J.P. reports being chair of the medical advisory board for liraglutide and has received payment for consultancy from Astra Zeneca and Eli Lilly. J.P. is on the advisory board for bupropion/naltrexone and has given lectures for iNova pharmaceuticals unrelated to the submitted work. P.S. reports fees from Novo Nordisk for participation in a lecture unrelated to the submitted work.
: The Austin Health Human Research Ethics Committee approved this activity as an audit (Audit/21/Austin/10).